Corvus Pharmaceuticals, Inc. · NASDAQ:CRVS
Moore David Scott bought 21,700 Corvus Pharmaceuticals, Inc. shares (Form 4)
Traded Jun 11, 2026 · Filed Jun 15, 2026
On Jun 11, 2026, Moore David Scott (Director) bought 21,700 Corvus Pharmaceuticals, Inc. shares at US$11.53 for US$250K, leaving 21,700 shares. Filed Jun 15, 2026 (Form 4).
- Bought
- 21,700 shares
- Price
- US$11.53
- Value
- US$250K
- Holding after
- 21,700 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | Buy | 21,700 | US$11.53 | 21,700 | Direct |
Source
Related
- Corvus Pharmaceuticals, Inc.
- Moore David Scott
- Corvus Pharmaceuticals, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Miller Richard A Md · May 20, 2026
- Schedule 13G · Sirenia Capital Management LP · May 15, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026